However, these medications address only the acid component and do not directly treat nausea itself
Western blotting HTMCs were grown in the above-mentioned TMC medium in five 12-well plates at a density of 5 10 4 /ml for 24 h, and the medium was replaced with a new one, containing 1 l of water (negative control), TGF-1 (20 g/ml) or glucaric acid (10 mM) for 10 min
Beyond TRIUMPH: the TRANSCEND and SYNERGY programs Eli Lilly's retatrutide development extends beyond the TRIUMPH trials
They are consistent with the known side effect profile of GLP-1 receptor agonists already approved in the UK (see, for example, the Wegovy Summary of Product Characteristics, available via the electronic Medicines Compendium)
Asbaghi O, Ghanbari N, Shekari M, et al